| Dec 25 | |
|---|---|
| Income Statement | |
| Total Revenue | $ 0.00 |
| Gross Profit | $ 0.00 |
| Operating Income | $ -3.77M |
| EBITDA | $ -3.63M |
| Net Income | $ -3.85M |
| Balance Sheet | |
| Cash & Short-Term Investments | $ 236.40K |
| Total Assets | $ 481.60K |
| Total Debt | $ 1.66M |
| Net Debt | $ 1.42M |
| Total Liabilities | $ 2.45M |
| Stockholders' Equity | $ -1.96M |
| Cash Flow | |
| Free Cash Flow | $ -1.94M |
| Operating Cash Flow | $ -1.94M |
| Investing Cash Flow | $ 0.00 |
| Financing Cash Flow | $ 1.50M |
Lakewood-Amedex Biotherapeutics Inc. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.